The U.S. government has started holding talks with pharmaceutical manufacturers in compliance with the provisions of the Inflation Reduction Act (IRA) that allows Medicare to negotiate prices for some drugs.
The Centers for Medicare and Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure announced at a health conference in...
